MobileMums has a 98% probability of being cost-effective at a cost-effectiveness threshold of 64 000 AUD.
The CEAF (Fig. 2) shows that the probability of treat all being cost-effective, given a cost-effectiveness threshold value of £20,000, is 45%.
The probability of supported employment being cost-effective using the NICE lower cost-effectiveness threshold of £20,000/QALY is 67.1%, while at the NICE upper cost-effectiveness threshold of £30,000/QALY, it is 75.2%.
Using three times Taiwan's per capita GDP as the cost-effectiveness threshold, all these strategies were cost-effective.
In all cases, our results were found to be either cost-saving (dominant strategy) or within the recommended cost-effectiveness threshold to be considered a cost-effective intervention.
In that quadrant, a higher cost-effectiveness threshold reduces the probability of being cost-effective.
At a cost-effectiveness threshold of £20 000 the EUROACTION intervention will be cost-effective in under 6% of cases.
At a cost-effectiveness threshold of 64 000 AUD, the intervention can therefore be expected to be cost-effective.
However, if a cost-effectiveness threshold of £20,000 per QALY is applied, MRgFUS would be considered the cost-effective treatment strategy.
Nice's basic cost-effectiveness threshold for assessing value for money is also more than 15 years old and has not kept pace with either the cost of R&D or the NHS budget.
Drugs to treat people at the end of life should be judged more leniently, it was decided, with a cost-effectiveness threshold higher than the usual £30,000 for a year of good-quality life.
